描述
Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison.
Figure 14
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 14: Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison." /> <figcaption>Figure 14. Overall treatment response rates using composite IBS-SSS criteria are summarized for the synbiotic versus placebo comparison.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
相关证据
B
Bifidobacterium longum 用于 Irritable Bowel Syndrome (IBS)
B
等级 B · 4 项研究
Galactooligosaccharides (GOS) 用于 Irritable Bowel Syndrome (IBS)
B
等级 B · 3 项研究
Lactobacillus acidophilus 用于 Irritable Bowel Syndrome (IBS)
D
等级 B · 3 项研究
Fructooligosaccharides (FOS) 用于 Irritable Bowel Syndrome (IBS)
等级 D · 2 项研究